Portage Biotech
Portage Biotech

Dividends • Portage Biotech

PRTG

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
10/7/2024
10/21/2024
0,7
Quarterly
7/5/2024
7/19/2024
0,7
Quarterly
4/4/2024
4/19/2024
0,7
Quarterly
1/5/2024
1/22/2024
0,7
Quarterly
10/5/2023
10/20/2023
0,55
Quarterly
7/6/2023
7/21/2023
0,55
Quarterly
4/5/2023
4/21/2023
0,55
Quarterly
1/5/2023
1/20/2023
0,55
Quarterly